Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

16.7%

1 terminated out of 6 trials

Success Rate

0.0%

-86.5% vs benchmark

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

3Total
Not Applicable (1)
P 2 (1)
P 4 (1)

Trial Status

Unknown2
Recruiting2
Active Not Recruiting1
Terminated1

Clinical Trials (6)

Showing 6 of 6 trials
NCT06533631RecruitingPrimary

Measuring Brain Health Using Low-Field Portable MRI

NCT05586750Phase 4Active Not Recruiting

Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy

NCT06715007Recruiting

Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases

NCT04465448TerminatedPrimary

Evaluation of the Reproducibility of the Measurement of the QSM Signal (Quantitative Susceptibility Mapping)

NCT05982470Phase 2Unknown

Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI

NCT04532697Not ApplicableUnknown

Use of Gou-Teng to Treat Patients With Mild Cognitive Impairment

Showing all 6 trials

Research Network

Activity Timeline